0001192482-18-000344.txt : 20180718
0001192482-18-000344.hdr.sgml : 20180718
20180718162134
ACCESSION NUMBER: 0001192482-18-000344
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180614
FILED AS OF DATE: 20180718
DATE AS OF CHANGE: 20180718
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BAUER EUGENE A
CENTRAL INDEX KEY: 0001210524
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35112
FILM NUMBER: 18958633
MAIL ADDRESS:
STREET 1: C/O DERMIRA, INC.
STREET 2: 275 MIDDLEFIELD ROAD, SUITE 150
CITY: MENLO PARK
STATE: CA
ZIP: 94025
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aevi Genomic Medicine, Inc.
CENTRAL INDEX KEY: 0001138776
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 980217544
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 435 DEVON PARK DRIVE,
STREET 2: SUITE 715
CITY: WAYNE
STATE: PA
ZIP: 19087
BUSINESS PHONE: 610-254-4201
MAIL ADDRESS:
STREET 1: 435 DEVON PARK DRIVE,
STREET 2: SUITE 715
CITY: WAYNE
STATE: PA
ZIP: 19087
FORMER COMPANY:
FORMER CONFORMED NAME: MEDGENICS, INC.
DATE OF NAME CHANGE: 20090623
FORMER COMPANY:
FORMER CONFORMED NAME: MEDGENICS INC
DATE OF NAME CHANGE: 20010419
4/A
1
edgar.xml
PRIMARY DOCUMENT
X0306
4/A
2018-06-14
2018-06-18
0001138776
Aevi Genomic Medicine, Inc.
GNMX
0001210524
BAUER EUGENE A
C/O AEVI GENOMIC MEDICINE, INC.
435 DEVON PARK DRIVE, SUITE 715
WAYNE
PA
19087
1
0
0
0
Stock Option (Right to Purchase)
1.55
2018-06-14
4
A
0
50000
0
A
2028-04-17
Common Stock
50000
50000
D
The option award was granted on April 17, 2018 and was subject to forfeiture if stockholder approval of a proposed amendment to the Issuer's stock incentive plan to increase the number of shares reserved for issuance under the plan was not obtained. The Issuer's stockholders approved the amendment to the Issuer's stock incentive plan at the Issuer's annual meeting of stockholders on June 14, 2018.
This amendment is being filed to amend the vesting schedule of the option award. The entire option vests and becomes exercisable on April 17, 2019, subject to the reporting person's continued service with the Issuer.
/s/ Brian D. Piper as Attorney-in-Fact for Eugene A. Bauer
2018-07-18